SAFEGUARD SCIENTIFICS INC (SFES)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 15M 30M 45M FY09: 34.8M FY09

Gross Profit Annual

0 8M 16M 24M FY09: 21M FY09

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-10.5M -7M -3.5M 0 3.5M 7M 10.5M FY19: -10M FY20: -9.5M FY21: -7.2M FY22: -4.8M FY23: -5.7M FY19 FY20 FY21 FY22 FY23

Net Income Annual

-40M -20M 0 20M 40M 60M FY19: 54.6M FY20: -37.6M FY21: 27M FY22: -14.3M FY23: -9.8M FY19 FY20 FY21 FY22 FY23

Cost of Revenue Annual

0 5M 10M 15M FY09: 13.8M FY09

Operating Cash Flow Annual

-21M -14M -7M 0 7M 14M 21M FY19: -20M FY20: -8.1M FY21: -8.2M FY22: -3.3M FY23: -3.3M FY19 FY20 FY21 FY22 FY23

Free Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY13: -21.3M FY14: -20.2M FY15: -19.6M FY16: -19.1M FY17: -20.8M FY13 FY14 FY15 FY16 FY17

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 8M 16M 24M FY19: 20.6M FY20: 20.8M FY21: 19.8M FY22: 16.3M FY23: 16.2M FY19 FY20 FY21 FY22 FY23

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q1 '17: -1.63 Q2 '17: -4.76 Q3 '17: -4.49 Q4 '17: -4.33 Q1 '18: -3.55 Q2 '18: -3.33 Q3 '18: -0.86 Q4 '18: -0.76 Q1 '19: 0.59 Q2 '19: 3.55 Q3 '19: 1.87 Q4 '19: 2.65 Q1 '20: 0.83 Q2 '20: -1.40 Q3 '20: -1.49 Q4 '20: -1.81 Q1 '21: -0.20 Q2 '21: 0.26 Q3 '21: 1.35 Q4 '21: 1.19 Q2 '17 Q1 '18 Q4 '18 Q3 '19 Q2 '20 Q1 '21 Q4 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.